Tue. 13 Feb 2024, 4:43pm ET
Benzinga
Earnings, News
Anebulo Pharmaceuticals (NASDAQ:ANEB) reported quarterly losses of $(0.11) per share which missed the analyst consensus estimate of $(0.10) by 10 percent. This is a 26.67 percent increase over losses of $(0.15) per share from the same period last year.